ALIBX
Price
$12.25
Change
-$0.01 (-0.08%)
Updated
Jun 18 closing price
Net Assets
11.49M
CLBCX
Price
$35.66
Change
-$0.02 (-0.06%)
Updated
Jun 18 closing price
Net Assets
244.69B
Interact to see
Advertisement

ALIBX vs CLBCX

Header iconALIBX vs CLBCX Comparison
Open Charts ALIBX vs CLBCXBanner chart's image
ALPS/Smith Balanced Opportunity I
Price$12.25
Change-$0.01 (-0.08%)
VolumeN/A
Net Assets11.49M
American Funds American Balanced 529C
Price$35.66
Change-$0.02 (-0.06%)
VolumeN/A
Net Assets244.69B
ALIBX vs CLBCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
ALIBX vs. CLBCX commentary
Jun 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALIBX is a Buy and CLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CLBCX has more cash in the bank: 245B vs. ALIBX (11.5M). ALIBX pays higher dividends than CLBCX: ALIBX (1.64) vs CLBCX (1.18). ALIBX was incepted earlier than CLBCX: ALIBX (5 years) vs CLBCX (23 years). ALIBX (2.64) is less costly to investors than CLBCX (1.35). ALIBX is a more actively managed with annual turnover of: 131.00 vs. CLBCX (44.00). CLBCX has a lower initial minimum investment than ALIBX: CLBCX (250) vs ALIBX (2500). CLBCX annual gain was more profitable for investors over the last year : 3.68 vs. ALIBX (-2.39).
ALIBXCLBCXALIBX / CLBCX
Total Expense Ratio1.151.3585%
Annual Report Gross Expense Ratio2.641.35196%
Fund Existence5 years23 years-
Gain YTD1.1374.15527%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets11.5M245B0%
Annual Yield % from dividends1.641.18138%
Returns for 1 year-2.393.68-65%
Returns for 3 years28.9332.2490%
Returns for 5 yearsN/A34.22-
Returns for 10 yearsN/A57.15-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DEFT2.820.07
+2.55%
DEFI Technologies Inc
CC11.000.26
+2.42%
Chemours Company (The)
SGMT7.040.16
+2.33%
Sagimet Biosciences
RPAY4.600.01
+0.22%
Repay Holdings Corp
ONC252.78-1.31
-0.52%
BeOne Medicines Ltd